CRYSTALLINE (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,B]INDOL]-4-AMINE
The present invention relates to crystalline forms A, B, C, D, E and F of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro [cyclohexane-1-1'-pyrano[3,4,b]indo]-4-amine. The present invention also relates to pharmaceutical compositions and medicaments comprising these modifications, the use of these modifications, for example in compositions for the treatment of pain in a subject with a pain disorder, as well as to process for the enrichment of them..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Europäisches Patentamt - (2020) vom: 15. Dez. Zur Gesamtaufnahme - year:2020 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
GRUSS MICHAEL [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-12-15, Last update posted on www.tib.eu: 2023-07-24, Last updated: 2023-07-28 |
---|
Patentnummer: |
CA2841032 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA008315620 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA008315620 | ||
003 | DE-627 | ||
005 | 20230728085720.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210531s2020 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA008315620 | ||
035 | |a (EPA)CA2841032 | ||
035 | |a (EPA)46717800 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a GRUSS MICHAEL |e verfasserin |4 aut | |
245 | 1 | 0 | |a CRYSTALLINE (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,B]INDOL]-4-AMINE |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2020-12-15, Last update posted on www.tib.eu: 2023-07-24, Last updated: 2023-07-28 | ||
520 | |a The present invention relates to crystalline forms A, B, C, D, E and F of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro [cyclohexane-1-1'-pyrano[3,4,b]indo]-4-amine. The present invention also relates to pharmaceutical compositions and medicaments comprising these modifications, the use of these modifications, for example in compositions for the treatment of pain in a subject with a pain disorder, as well as to process for the enrichment of them. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a PRUHS STEFAN |4 aut | |
700 | 0 | |a KLUGE STEFAN |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 15. Dez. |
773 | 1 | 8 | |g year:2020 |g day:15 |g month:12 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/46717800/publication/CA2841032A1?q=CA2841032 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2020 |b 15 |c 12 |
951 | |a AR | ||
952 | |j 2020 |b 15 |c 12 |